Healthcare of Ontario Pension Plan Trust Fund Has $18.80 Million Stake in Xylem Inc. $XYL

Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Xylem Inc. (NYSE:XYL) by 197.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 157,304 shares of the industrial products company’s stock after buying an additional 104,480 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Xylem were worth $18,798,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Renaissance Technologies LLC grew its holdings in Xylem by 120.3% during the 1st quarter. Renaissance Technologies LLC now owns 791,771 shares of the industrial products company’s stock worth $94,617,000 after acquiring an additional 432,400 shares during the period. Compound Planning Inc. raised its position in shares of Xylem by 11.2% during the 1st quarter. Compound Planning Inc. now owns 2,512 shares of the industrial products company’s stock valued at $300,000 after acquiring an additional 254 shares during the last quarter. Modern Wealth Management LLC lifted its stake in shares of Xylem by 31.6% in the 1st quarter. Modern Wealth Management LLC now owns 8,971 shares of the industrial products company’s stock valued at $1,099,000 after purchasing an additional 2,153 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of Xylem by 4,058.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 399,860 shares of the industrial products company’s stock worth $47,783,000 after purchasing an additional 390,245 shares during the last quarter. Finally, Caxton Associates LLP acquired a new stake in shares of Xylem during the first quarter worth $2,423,000. 87.96% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Barclays cut their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. UBS Group increased their price target on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Jefferies Financial Group raised shares of Xylem from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $130.00 to $140.00 in a research note on Thursday, June 25th. Stifel Nicolaus decreased their price objective on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a report on Monday, July 20th. Finally, CLSA raised shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $153.15.

Xylem Price Performance

Shares of XYL opened at $120.20 on Tuesday. The stock has a 50 day simple moving average of $114.27 and a 200 day simple moving average of $122.55. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The firm has a market capitalization of $28.57 billion, a PE ratio of 29.90, a P/E/G ratio of 1.70 and a beta of 1.03.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same period last year, the company posted $1.03 EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. Sell-side analysts predict that Xylem Inc. will post 5.52 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. Xylem’s dividend payout ratio is currently 42.79%.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.